摘要
Rationale: Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs) involved in the regulation of the immune system and displayed a cell-type-specific pattern in immune cell subsets. Given the vital role of tumor-infiltrating lymphocytes in effective immunotherapy, we explored the tumor-infiltrating immune cell-associated lncRNA (TIIClncRNA) in low-grade glioma (LGG), which has never been uncovered yet. @@@ Methods: This study utilized a novel computational framework and 10 machine learning algorithms (101 combinations) to screen out TIIClncRNAs by integratively analyzing the sequencing data of purified immune cells, LGG cell lines, and bulk LGG tissues. @@@ Results: The established TIICInc signature based on the 16 most potent TIIClncRNAs could predict outcomes in public datasets and the Xiangya in-house dataset with decent efficiency and showed better performance when compared with 95 published signatures. The TIIClnc signature was strongly correlated to immune characteristics, including microsatellite instability, tumor mutation burden, and interferon gamma, and exhibited a more active immunologic process. Furthermore, the TIIClnc signature predicted superior immunotherapy response in multiple datasets across cancer types. Notably, the positive correlation between the TIIClnc signature and CD8, PD-1, and PD-L1 was verified in the Xiangya in-house dataset. @@@ Conclusions: The TIIClnc signature enabled a more precise selection of the LGG population who were potential beneficiaries of immunotherapy.
学科与关键词
- Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy responseWang, Nan; Gao, Xin; Ji, Hang; Ma, Shuai; Wu, Jiasheng; Dong, Jiawei; Wang, Fang; Zhao, Hongtao; Liu, Zhihui; Yan, Xiuwei; Li, Bo; Du, Jianyang*; Zhang, Jiheng*; Hu, Shaoshan*Frontiers in Molecular Biosciences, 2022, 9: 942966.
- Identification and Validation of Immune-Related Long Non-Coding RNA Signature for Predicting Immunotherapeutic Response and Prognosis in NSCLC Patients Treated With ImmunotherapyMa, Jianli; Zhang, Minghui; Yu, Jinming*Frontiers in Oncology, 2022, 12: 899925.被引 5
- A TGF-β signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy responseDuan, Wei-Wei; Yang, Li-Ting; Liu, Jian; Dai, Zi-Yu; Wang, Ze-Yu; Zhang, Hao; Zhang, Xun; Liang, Xi-Song; Luo, Peng; Zhang, Jian; Liu, Zao-Qu; Zhang, Nan; Mo, Hao-Yang; Qu, Chun-Run; Xia, Zhi-Wei*; Cheng, Quan*CNS Neuroscience & Therapeutics, 2023.
